KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Clorox (CLX) over the last 16 years, with Q4 2025 value amounting to $2.3 billion.

  • Clorox's Total Current Liabilities rose 3566.47% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 3566.47%. This contributed to the annual value of $1.9 billion for FY2025, which is 2191.87% up from last year.
  • Latest data reveals that Clorox reported Total Current Liabilities of $2.3 billion as of Q4 2025, which was up 3566.47% from $2.2 billion recorded in Q3 2025.
  • In the past 5 years, Clorox's Total Current Liabilities ranged from a high of $2.6 billion in Q1 2022 and a low of $1.6 billion during Q2 2024
  • Its 5-year average for Total Current Liabilities is $2.0 billion, with a median of $2.0 billion in 2022.
  • In the last 5 years, Clorox's Total Current Liabilities surged by 7407.65% in 2021 and then crashed by 2912.93% in 2024.
  • Clorox's Total Current Liabilities (Quarter) stood at $2.6 billion in 2021, then decreased by 27.66% to $1.9 billion in 2022, then grew by 7.67% to $2.0 billion in 2023, then fell by 14.44% to $1.7 billion in 2024, then skyrocketed by 35.66% to $2.3 billion in 2025.
  • Its Total Current Liabilities was $2.3 billion in Q4 2025, compared to $2.2 billion in Q3 2025 and $1.9 billion in Q2 2025.